Chronic News and Research

RSS

Machine learning and proteomics predict cardiovascular risk more accurately

An innovative proteomics-based model that predicts the risk of cardiovascular events with higher accuracy than current clinical models.

10 Apr 2022

Wireless remote care platform may help manage neurological disorders at home

Many neurological disorders like Parkinson's, chronic depression and other psychiatric conditions could be managed at home, thanks to a collaborative project involving researchers at the University of Queensland (UQ).

10 Apr 2022

Imbalances in the intestinal virome may promote inflammatory bowel disease, research shows

Research in recent years has demonstrated the diverse roles that gut bacteria can play in health and disease, but what about contributions from viruses, which, like bacteria, perpetually reside within the human intestine?

8 Apr 2022

New Alzheimer’s disease hypothesis could open up diagnosis or treatment possibilities

Alzheimer's Disease could be caused by damage to a protective barrier in the body that allows fatty substances to build up in the brain, newly published research argues.

8 Apr 2022

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease

A hormone that triggers puberty and controls fertility in humans might be developed as a treatment for non-alcoholic fatty liver disease, according to new Rutgers research.

7 Apr 2022

NHLBI researchers support multiple programs to address pregnancy-related health disparities

During Black Maternal Health Week, April 11-17, and in preparation for Women's Health Month in May, researchers are raising awareness about pregnancy-related complications that disproportionately affect Black people.

7 Apr 2022

Nobel-prize-winning breakthrough: Discovery of ion-channel sensors for temperature and pressure

For centuries, understanding the basis for how we detect, process and react to light, sound, temperature, pressure and other environmental signals has been a scientific focus.

7 Apr 2022

Researchers reveal why people with allergic asthma are protected from severe COVID

The vast majority of people infected with the omicron variant of SARS-CoV-2 experience mild cold-like symptoms, moderate flu-like symptoms, or no symptoms at all, but the virus is so transmissible that it still spread deep into lung tissue to cause severe disease and death in thousands of people in the United States in 2022 alone.

7 Apr 2022

Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

A recent study analyzed the antibody that mediated the COVID-19 vaccine-induced thrombotic thrombocytopenia.

7 Apr 2022

International Health Partners; Bringing Hope to Vulnerable Communities

In this interview, we speak to Adele Paterson, CEO of International Health Partners, about how they are bringing hope to vulnerable communities worldwide.

7 Apr 2022

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

A recent study posted to the medRxiv* preprint server investigated the elements that predicted all-cause mortality among individuals hospitalized due to influenza, respiratory syncytial virus (RSV), or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

7 Apr 2022

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

A recent study posted to the medRxiv* preprint server investigated the association of renin-angiotensin-aldosterone system (RAAS)-mediated hypertension (HT) with coronavirus disease 2019 (COVID-19).

6 Apr 2022

Insufficient sleep could play a role in the development of type 2 diabetes

People who have difficulty getting to sleep or staying asleep had higher blood sugar levels than people who rarely had sleep issues, new research has found.

6 Apr 2022

People with some types of epilepsy may have a lower quality of life, study suggests

A new study suggests that people with epilepsy associated with head injuries, especially the type not well controlled by medication, are more likely to have other health conditions like depression, post-traumatic stress disorder (PTSD), back pain and headache that may result in them reporting a lower quality of life.

6 Apr 2022

Chronic News and Research

Machine learning and proteomics predict cardiovascular risk more accurately

Wireless remote care platform may help manage neurological disorders at home

Imbalances in the intestinal virome may promote inflammatory bowel disease, research shows

New Alzheimer’s disease hypothesis could open up diagnosis or treatment possibilities

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease

NHLBI researchers support multiple programs to address pregnancy-related health disparities

Nobel-prize-winning breakthrough: Discovery of ion-channel sensors for temperature and pressure

Researchers reveal why people with allergic asthma are protected from severe COVID

Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

International Health Partners; Bringing Hope to Vulnerable Communities

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

Insufficient sleep could play a role in the development of type 2 diabetes

People with some types of epilepsy may have a lower quality of life, study suggests

Study investigates the breast milk microbiome in HIV-positive mothers

Insights into the pathophysiology of NeuroCOVID

World Health Day; Creating a Better Planet for a #HealthierTomorrow

How comorbidities impact antibody response to COVID vaccination

New technique can reliably identify patients most likely to suffer post-surgery pain

HIV drug stops disease progression in 25% of patients with fourth-line metastatic colorectal cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News